CD33 single nucleotide polymorphisms (SNPs) have been implicated in the risk of Alzheimer's disease (AD) and the therapeutic efficacy of acute myeloid leukemia (AML) (59). The gene discussed is CD33; the disease is acute myeloid leukemia.